Main
>
MEDICINE
>
Sclerosis.
>
Diffuse Systemic Sclerosis
>
ImmunoTherapy
>
Human TGF MAb
>
Clinical Status: Phase II (08.03)
Clinical Status: Phase II (08.03)'s products
This section has no products